East Northport, New York (PRWEB) November 20, 2016
Acutis Diagnostics, a New York headquartered clinical toxicology laboratory, has announced that it has acquired 11,000 square feet of additional space in East Northport, New York to support the ongoing growth of its medication monitoring and drugs of abuse testing operations. The new facility is designed with state of the art clinical laboratorial amenities.
The CEO of Acutis Diagnostics, Jibreel Sarij, commented that “the expansion into a state of the art facility for clinical toxicology testing reinforces our ability to provide exceptional service to our clients and a welcoming workspace for our team of professionals."
Dr. Marjorie Bon Homme, chief toxicologist at Acutis Diagnostics, went on to say that “as part of our expansion we have put into place an advanced automation system which further reinforce our industry leading turnaround times for confirmation drug testing while also enabling the highest standards of quality controls.”
Acutis Diagnostics is a fully accredited clinical toxicological laboratory licensed under the state of New York’s CLEP program. The laboratory performs medication monitoring tests on urine and oral fluids. Our clients include major hospital groups, pain management practices, substance abuse programs, general practitioners and psychiatric practices, amongst other specialties. We strive to exceed standards of testing for drugs of abuse and medication monitoring, provide exceptional service and work with the highest levels of ethics.